Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study

Int J Dermatol. 2024 Mar;63(3):402-404. doi: 10.1111/ijd.17030. Epub 2024 Jan 16.

Authors

Miguel A Lasheras-Pérez¹, Rodolfo D Palacios-Diaz¹, Víctor A González-Delgado², Lorena V Cobreros³, Gabriel O Pereira-Resquin Galván³, Javier Miquel-Miquel³, Carolina Labrandero Hoyos⁴, Violeta Zaragoza Ninet⁴, Francisco J Melgosa Ramos⁵, José M Sánchez-Motilla⁵, Fernando Navarro-Blanco¹, Daniel Martín-Torregrosa¹, Rafael Botella-Estrada¹, Mercedes Rodríguez-Serna¹

Affiliations

¹ Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain.
² Department of Dermatology, Valencia University Clinical Hospital, Valencia, Spain.
³ Department of Dermatology, University Hospital Arnau de Vilanova, Valencia, Spain.
⁴ Department of Dermatology, Valencia General Hospital, Valencia, Spain.
⁵ Department of Dermatology, Hospital Doctor Peset, Valencia, Spain.

PMID: 38229523
DOI: 10.1111/ijd.17030

No abstract available

Publication types

Multicenter Study
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Cohort Studies
Dermatitis, Atopic* / drug therapy
Double-Blind Method
Drug Tapering
Humans
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
Antibodies, Monoclonal, Humanized